Absci to Participate in the BofA Securities 2021 Tech Solutions for Drug Discovery Conference

Rhea-AI Summary

Absci Corporation (Nasdaq: ABSI) announced its participation in the BofA Securities 2021 Tech Solutions for Drug Discovery Conference. The virtual presentation is scheduled for September 20 at 2:00 p.m. PT / 5:00 p.m. ET. Attendees can access the live and archived webcast on Absci's website.

Absci utilizes deep learning and synthetic biology to enhance protein therapeutic potential through its Integrated Drug Creation™ Platform, aimed at discovering drug targets and optimal biotherapeutics efficiently.

VANCOUVER, Wash., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning and synthetic biology to expand the therapeutic potential of proteins, today announced the company will be participating virtually in the upcoming BofA Securities 2021 Tech Solutions for Drug Discovery Conference.

Absci’s management is scheduled to present on Monday, September 20 at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at www.absci.com.

About Absci

Absci is the drug and target discovery company harnessing deep learning and synthetic biology to expand the therapeutic potential of proteins. We built our Integrated Drug Creation™ Platform to identify novel drug targets, discover optimal biotherapeutic candidates, and generate the cell lines to manufacture them in a single efficient process. Biotech and pharma innovators partner with us to create the next generation of protein-based drugs, including those that may be impossible to make with other technologies. Our goal is to enable the development of better medicines by Translating Ideas into Drugs™. For more information visit www.absci.com.

Availability of Other Information about Absci

Investors and others should note that we routinely communicate with investors and the public using our website (www.absci.com) and our investor relations website (investors.absci.com), including without limitation, through the posting of investor presentations, SEC filings, press releases, public conference calls and webcasts on these websites. The information that we post on these websites could be deemed to be material information. As a result, investors, the media, and others interested in Absci are encouraged to review this information on a regular basis. The contents of our website, or any other website that may be accessed from our website, shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended.

Investor Contact

investors@absci.com

Media Contact

press@absci.com

FAQ

When is Absci Corporation's presentation at the BofA Securities 2021 Conference?

Absci Corporation's presentation is scheduled for September 20, 2021, at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time.

What is the focus of Absci Corporation's technology?

Absci Corporation focuses on drug and target discovery using deep learning and synthetic biology to expand the therapeutic potential of proteins.

Where can I watch Absci's presentation from the BofA Conference?

You can watch Absci's presentation live and access the archived webcast on their website under the 'Investors' section.

What is the purpose of Absci's Integrated Drug Creation™ Platform?

The Integrated Drug Creation™ Platform is designed to identify novel drug targets, discover optimal biotherapeutic candidates, and generate manufacturing cell lines in a single process.

How does Absci Corporation communicate with investors?

Absci routinely communicates with investors through its website, including posting investor presentations, SEC filings, and press releases.